These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 36336129)

  • 1. The hepatoprotective effects of n3-polyunsaturated fatty acids against non-alcoholic fatty liver disease in diabetic rats through the FOXO1/PPARα/GABARAPL1 signalling pathway.
    Ramadan NM; Elmasry K; Elsayed HRH; El-Mesery A; Eraky SM
    Life Sci; 2022 Dec; 311(Pt A):121145. PubMed ID: 36336129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NLRP3 inhibitor glibenclamide attenuates high-fat diet and streptozotocin-induced non-alcoholic fatty liver disease in rat: studies on oxidative stress, inflammation, DNA damage and insulin signalling pathway.
    Dwivedi DK; Jena GB
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):705-716. PubMed ID: 31834465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats.
    Li S; Liao X; Meng F; Wang Y; Sun Z; Guo F; Li X; Meng M; Li Y; Sun C
    PLoS One; 2014; 9(1):e86724. PubMed ID: 24489777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal ethanol exposure programs an increased susceptibility of non-alcoholic fatty liver disease in female adult offspring rats.
    Shen L; Liu Z; Gong J; Zhang L; Wang L; Magdalou J; Chen L; Wang H
    Toxicol Appl Pharmacol; 2014 Jan; 274(2):263-73. PubMed ID: 24275070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium Butyrate Ameliorates High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease through Peroxisome Proliferator-Activated Receptor α-Mediated Activation of β Oxidation and Suppression of Inflammation.
    Sun B; Jia Y; Hong J; Sun Q; Gao S; Hu Y; Zhao N; Zhao R
    J Agric Food Chem; 2018 Jul; 66(29):7633-7642. PubMed ID: 29961332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salidroside inhibits insulin resistance and hepatic steatosis by downregulating miR-21 and subsequent activation of AMPK and upregulation of PPARα in the liver and muscles of high fat diet-fed rats.
    Almohawes ZN; El-Kott A; Morsy K; Shati AA; El-Kenawy AE; Khalifa HS; Elsaid FG; Abd-Lateif AM; Abu-Zaiton A; Ebealy ER; Abdel-Daim MM; Ghanem RA; Abd-Ella EM
    Arch Physiol Biochem; 2024 Jun; 130(3):257-274. PubMed ID: 35061559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Betaine prevented fructose-induced NAFLD by regulating LXRα/PPARα pathway and alleviating ER stress in rats.
    Ge CX; Yu R; Xu MX; Li PQ; Fan CY; Li JM; Kong LD
    Eur J Pharmacol; 2016 Jan; 770():154-64. PubMed ID: 26593707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-obesogenic effects of WY14643 (PPAR-alpha agonist): Hepatic mitochondrial enhancement and suppressed lipogenic pathway in diet-induced obese mice.
    Veiga FMS; Graus-Nunes F; Rachid TL; Barreto AB; Mandarim-de-Lacerda CA; Souza-Mello V
    Biochimie; 2017 Sep; 140():106-116. PubMed ID: 28711683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-3 PUFAs inhibited hepatic ER stress induced by feeding of a high-saturated fat diet accompanied by the expression LOX-1.
    Zhang J; Yang P; Wang H; Huang Q; Chen T; Li N; Zhang H; Liu Z
    J Nutr Biochem; 2021 Feb; 88():108481. PubMed ID: 32853678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of Electroacupunctrue Combined with Dietary Control on Peroxisome Proliferator-activa- ted Receptor-α, and Liver Fatty Acid-binding Protein Levels in Non-alcoholic Fatty Liver Disease Rats].
    Zhang Y; Tang CL; Tian Y; Yuan HZ; Yang H; Tang NZ; Gao RQ; Cao J
    Zhen Ci Yan Jiu; 2015 Oct; 40(5):345-51. PubMed ID: 26669188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LB100 ameliorates nonalcoholic fatty liver disease
    Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
    World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice.
    Li X; Wang Z; Klaunig JE
    Toxicology; 2019 Mar; 416():1-14. PubMed ID: 30711707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα.
    Zhang R; Yu Y; Hu S; Zhang J; Yang H; Han B; Cheng Y; Luo X
    Nutr Res; 2016 Sep; 36(9):1022-1030. PubMed ID: 27632923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin in Combination with Malvidin Prevents Progression of Non-Alcoholic Fatty Liver Disease via Improving Lipid and Glucose Metabolisms, and Inhibiting Inflammation in Type 2 Diabetes Rats.
    Zou W; Zhang C; Gu X; Li X; Zhu H
    Drug Des Devel Ther; 2021; 15():2565-2576. PubMed ID: 34168429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PARP1-mediated PPARα poly(ADP-ribosyl)ation suppresses fatty acid oxidation in non-alcoholic fatty liver disease.
    Huang K; Du M; Tan X; Yang L; Li X; Jiang Y; Wang C; Zhang F; Zhu F; Cheng M; Yang Q; Yu L; Wang L; Huang D; Huang K
    J Hepatol; 2017 May; 66(5):962-977. PubMed ID: 27979751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury.
    Svegliati-Baroni G; Candelaresi C; Saccomanno S; Ferretti G; Bachetti T; Marzioni M; De Minicis S; Nobili L; Salzano R; Omenetti A; Pacetti D; Sigmund S; Benedetti A; Casini A
    Am J Pathol; 2006 Sep; 169(3):846-60. PubMed ID: 16936261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of bile acid composition in high fat diet-induced nonalcoholic fatty liver disease in obese diabetic rats.
    Nakade Y; Kitano R; Sakamoto K; Kimoto S; Yamauchi T; Inoue T; Kobayashi Y; Ohashi T; Sumida Y; Ito K; Yoneda M
    PLoS One; 2021; 16(2):e0247303. PubMed ID: 33626072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Roles of MicroRNA-21 in the Pathogenesis of Insulin Resistance and Diabetic Mellitus-induced Non-alcoholic Fatty Liver Disease].
    Zhao XY; Shao K
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Apr; 38(2):144-9. PubMed ID: 27181889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eburicoic Acid, a Triterpenoid Compound from Antrodia camphorata, Displays Antidiabetic and Antihyperlipidemic Effects in Palmitate-Treated C2C12 Myotubes and in High-Fat Diet-Fed Mice.
    Lin CH; Kuo YH; Shih CC
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ascorbic acid inhibits visceral obesity and nonalcoholic fatty liver disease by activating peroxisome proliferator-activated receptor α in high-fat-diet-fed C57BL/6J mice.
    Lee H; Ahn J; Shin SS; Yoon M
    Int J Obes (Lond); 2019 Aug; 43(8):1620-1630. PubMed ID: 30283077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.